Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism.

Clinical trial NCT03199430 · COMPLETED

Trial details

NCT number: NCT03199430
Sponsor: Swansea University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

EGCG Influence on Catecholamine Metabolism

Start date: 2015-09-01
Primary completion: 2016-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.